Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198


Nonaxisymmetric simulations of the Princeton magnetorotational instability experiment with insulating and conducting axial boundaries.

Choi D, Ebrahimi F, Caspary KJ, Gilson EP, Goodman J, Ji H.

Phys Rev E. 2019 Sep;100(3-1):033116. doi: 10.1103/PhysRevE.100.033116.


The Tara Pacific expedition-A pan-ecosystemic approach of the "-omics" complexity of coral reef holobionts across the Pacific Ocean.

Planes S, Allemand D, Agostini S, Banaigs B, Boissin E, Boss E, Bourdin G, Bowler C, Douville E, Flores JM, Forcioli D, Furla P, Galand PE, Ghiglione JF, Gilson E, Lombard F, Moulin C, Pesant S, Poulain J, Reynaud S, Romac S, Sullivan MB, Sunagawa S, Thomas OP, Troublé R, de Vargas C, Vega Thurber R, Voolstra CR, Wincker P, Zoccola D; Tara Pacific Consortium.

PLoS Biol. 2019 Sep 23;17(9):e3000483. doi: 10.1371/journal.pbio.3000483. eCollection 2019 Sep.


Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells.

Cherfils-Vicini J, Gilson E.

EMBO Mol Med. 2019 Jul;11(7):e10845. doi: 10.15252/emmm.201910845. Epub 2019 Jun 13.


Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2.

Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, Shkreli M, Vivier E, Biroccio A, Gilson E.

EMBO J. 2019 Jun 3;38(11). pii: e100012. doi: 10.15252/embj.2018100012. Epub 2019 Apr 18.


Turbulence and jet-driven zonal flows: Secondary circulation in rotating fluids due to asymmetric forcing.

Burin MJ, Caspary KJ, Edlund EM, Ezeta R, Gilson EP, Ji H, McNulty M, Squire J, Tynan GR.

Phys Rev E. 2019 Feb;99(2-1):023108. doi: 10.1103/PhysRevE.99.023108.


The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.

Hofman P, Ayache N, Barbry P, Barlaud M, Bel A, Blancou P, Checler F, Chevillard S, Cristofari G, Demory M, Esnault V, Falandry C, Gilson E, Guérin O, Glaichenhaus N, Guigay J, Ilié M, Mari B, Marquette CH, Paquis-Flucklinger V, Prate F, Saintigny P, Seitz-Polsky B, Skhiri T, Van Obberghen-Schilling E, Van Obberghen E, Yvan-Charvet L.

Cancers (Basel). 2019 Feb 21;11(2). pii: E250. doi: 10.3390/cancers11020250.


TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.

Zizza P, Dinami R, Porru M, Cingolani C, Salvati E, Rizzo A, D'Angelo C, Petti E, Amoreo CA, Mottolese M, Sperduti I, Chambery A, Russo R, Ostano P, Chiorino G, Blandino G, Sacconi A, Cherfils-Vicini J, Leonetti C, Gilson E, Biroccio A.

Nucleic Acids Res. 2019 Apr 23;47(7):3365-3382. doi: 10.1093/nar/gkz041.


Design and implementation of a Thomson parabola for fluence dependent energy-loss measurements at the Neutralized Drift Compression eXperiment.

Treffert F, Ji Q, Seidl PA, Persaud A, Ludewigt B, Barnard JJ, Friedman A, Grote DP, Gilson EP, Kaganovich ID, Stepanov A, Roth M, Schenkel T.

Rev Sci Instrum. 2018 Oct;89(10):103302. doi: 10.1063/1.5030541.


A multi-species powder dropper for magnetic fusion applications.

Nagy A, Bortolon A, Mauzey DM, Wolfe E, Gilson EP, Lunsford R, Maingi R, Mansfield DK, Nazikian R, Roquemore AL.

Rev Sci Instrum. 2018 Oct;89(10):10K121. doi: 10.1063/1.5039345.


Analysis of DNA-Protein Complexes by Atomic Force Microscopy Imaging: The Case of TRF2-Telomeric DNA Wrapping.

Pisano S, Gilson E.

Methods Mol Biol. 2019;1886:75-97. doi: 10.1007/978-1-4939-8894-5_5.


Effects of axial boundary conductivity on a free Stewartson-Shercliff layer.

Caspary KJ, Choi D, Ebrahimi F, Gilson EP, Goodman J, Ji H.

Phys Rev E. 2018 Jun;97(6-1):063110. doi: 10.1103/PhysRevE.97.063110.


Genome-wide Control of Heterochromatin Replication by the Telomere Capping Protein TRF2.

Mendez-Bermudez A, Lototska L, Bauwens S, Giraud-Panis MJ, Croce O, Jamet K, Irizar A, Mowinckel M, Koundrioukoff S, Nottet N, Almouzni G, Teulade-Fichou MP, Schertzer M, Perderiset M, Londoño-Vallejo A, Debatisse M, Gilson E, Ye J.

Mol Cell. 2018 May 3;70(3):449-461.e5. doi: 10.1016/j.molcel.2018.03.036.


TRFH domain: at the root of telomere protein evolution?

Giraud-Panis MJ, Ye J, Gilson E.

Cell Res. 2018 Jan;28(1):7-8. doi: 10.1038/cr.2017.152. Epub 2017 Dec 1.


Dynamics under the Telomeric Bridge.

Pisano S, Gilson E, Giraud-Panis MJ.

Mol Cell. 2017 Nov 16;68(4):643-644. doi: 10.1016/j.molcel.2017.11.005. Review.


The differential spatiotemporal expression pattern of shelterin genes throughout lifespan.

Wagner KD, Ying Y, Leong W, Jiang J, Hu X, Chen Y, Michiels JF, Lu Y, Gilson E, Wagner N, Ye J.

Aging (Albany NY). 2017 Apr;9(4):1219-1232. doi: 10.18632/aging.101223.


Test anxiety and telomere length: Academic stress in adolescents may not cause rapid telomere erosion.

Zou Y, Leong W, Yao M, Hu X, Lu S, Zhu X, Chen L, Tong J, Shi J, Gilson E, Ye J, Lu Y.

Oncotarget. 2017 Feb 14;8(7):10836-10844. doi: 10.18632/oncotarget.14793.


Numerical simulations of the Princeton magnetorotational instability experiment with conducting axial boundaries.

Wei X, Ji H, Goodman J, Ebrahimi F, Gilson E, Jenko F, Lackner K.

Phys Rev E. 2016 Dec;94(6-1):063107. doi: 10.1103/PhysRevE.94.063107. Epub 2016 Dec 16.


SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage.

Rizzo A, Iachettini S, Salvati E, Zizza P, Maresca C, D'Angelo C, Benarroch-Popivker D, Capolupo A, Del Gaudio F, Cosconati S, Di Maro S, Merlino F, Novellino E, Amoreo CA, Mottolese M, Sperduti I, Gilson E, Biroccio A.

Nucleic Acids Res. 2017 Feb 28;45(4):1820-1834. doi: 10.1093/nar/gkw1202.


nor-BNI Antagonism of Kappa Opioid Agonist-Induced Reinstatement of Ethanol-Seeking Behavior.

Harshberger E, Gilson EA, Gillett K, Stone JH, El Amrani L, Valdez GR.

J Addict. 2016;2016:1084235. Epub 2016 Nov 6.


Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells.

Douguet L, Cherfils-Vicini J, Bod L, Lengagne R, Gilson E, Prévost-Blondel A.

PLoS One. 2016 Nov 3;11(11):e0165639. doi: 10.1371/journal.pone.0165639. eCollection 2016.


ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2.

Picco V, Coste I, Giraud-Panis MJ, Renno T, Gilson E, Pagès G.

Oncotarget. 2016 Jul 19;7(29):46615-46627. doi: 10.18632/oncotarget.10316.


TRF2 acts as a transcriptional regulator in tumor angiogenesis.

Maï ME, Wagner KD, Michiels JF, Gilson E, Wagner N.

Mol Cell Oncol. 2015 Jan 23;2(3):e988508. doi: 10.4161/23723556.2014.988508. eCollection 2015 Jul-Sep.


High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.

Long E, Ilie M, Bence C, Butori C, Selva E, Lalvée S, Bonnetaud C, Poissonnet G, Lacour JP, Bahadoran P, Brest P, Gilson E, Ballotti R, Hofman V, Hofman P.

Cancer Med. 2016 Jun;5(6):1022-30. doi: 10.1002/cam4.661. Epub 2016 Mar 6.


Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells.

Nassour J, Martien S, Martin N, Deruy E, Tomellini E, Malaquin N, Bouali F, Sabatier L, Wernert N, Pinte S, Gilson E, Pourtier A, Pluquet O, Abbadie C.

Nat Commun. 2016 Jan 29;7:10399. doi: 10.1038/ncomms10399.


TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End Protection.

Benarroch-Popivker D, Pisano S, Mendez-Bermudez A, Lototska L, Kaur P, Bauwens S, Djerbi N, Latrick CM, Fraisier V, Pei B, Gay A, Jaune E, Foucher K, Cherfils-Vicini J, Aeby E, Miron S, Londoño-Vallejo A, Ye J, Le Du MH, Wang H, Gilson E, Giraud-Panis MJ.

Mol Cell. 2016 Jan 21;61(2):274-86. doi: 10.1016/j.molcel.2015.12.009. Epub 2016 Jan 7.


A higher-order entity formed by the flexible assembly of RAP1 with TRF2.

Gaullier G, Miron S, Pisano S, Buisson R, Le Bihan YV, Tellier-Lebègue C, Messaoud W, Roblin P, Guimarães BG, Thai R, Giraud-Panis MJ, Gilson E, Le Du MH.

Nucleic Acids Res. 2016 Feb 29;44(4):1962-76. doi: 10.1093/nar/gkv1531. Epub 2016 Jan 8.


Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study.

Falandry C, Horard B, Bruyas A, Legouffe E, Cretin J, Meunier J, Alexandre J, Delecroix V, Fabbro M, Certain MN, Maraval-Gaget R, Pujade-Lauraine E, Gilson E, Freyer G.

Aging (Albany NY). 2015 Dec;7(12):1066-76.


Biological reduction of uranium coupled with oxidation of ammonium by Acidimicrobiaceae bacterium A6 under iron reducing conditions.

Gilson ER, Huang S, Jaffé PR.

Biodegradation. 2015 Nov;26(6):475-82. doi: 10.1007/s10532-015-9749-y. Epub 2015 Nov 2.


Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance.

Zizza P, Cingolani C, Artuso S, Salvati E, Rizzo A, D'Angelo C, Porru M, Pagano B, Amato J, Randazzo A, Novellino E, Stoppacciaro A, Gilson E, Stassi G, Leonetti C, Biroccio A.

Nucleic Acids Res. 2016 Feb 29;44(4):1579-90. doi: 10.1093/nar/gkv1122. Epub 2015 Oct 27.


Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma.

Zhang L, Huang X, Zhu X, Ge S, Gilson E, Jia R, Ye J, Fan X.

Int J Cancer. 2016 Mar 15;138(6):1442-52. doi: 10.1002/ijc.29882. Epub 2015 Oct 23.


Uranium Redistribution Due to Water Table Fluctuations in Sandy Wetland Mesocosms.

Gilson ER, Huang S, Koster van Groos PG, Scheckel KG, Qafoku O, Peacock AD, Kaplan DI, Jaffé PR.

Environ Sci Technol. 2015 Oct 20;49(20):12214-22. doi: 10.1021/acs.est.5b02957. Epub 2015 Oct 2.


TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization.

Galati A, Micheli E, Alicata C, Ingegnere T, Cicconi A, Pusch MC, Giraud-Panis MJ, Gilson E, Cacchione S.

Nucleic Acids Res. 2015 Jul 13;43(12):5824-37. doi: 10.1093/nar/gkv507. Epub 2015 May 20.


A basal level of DNA damage and telomere deprotection increases the sensitivity of cancer cells to G-quadruplex interactive compounds.

Salvati E, Rizzo A, Iachettini S, Zizza P, Cingolani C, D'Angelo C, Porru M, Mondello C, Aiello A, Farsetti A, Gilson E, Leonetti C, Biroccio A.

Nucleic Acids Res. 2015 Feb 18;43(3):1759-69. doi: 10.1093/nar/gkv006. Epub 2015 Jan 23.


Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer.

Hofman P, Cherfils-Vicini J, Bazin M, Ilie M, Juhel T, Hébuterne X, Gilson E, Schmid-Alliana A, Boyer O, Adriouch S, Vouret-Craviari V.

Cancer Res. 2015 Mar 1;75(5):835-45. doi: 10.1158/0008-5472.CAN-14-1778. Epub 2015 Jan 6.


The topoisomerase II catalytic inhibitor ICRF-193 preferentially targets telomeres that are capped by TRF2.

Chen L, Zhu X, Zou Y, Xing J, Gilson E, Lu Y, Ye J.

Am J Physiol Cell Physiol. 2015 Mar 1;308(5):C372-7. doi: 10.1152/ajpcell.00321.2014. Epub 2014 Dec 17.


The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression.

Wagner KD, Cherfils-Vicini J, Hosen N, Hohenstein P, Gilson E, Hastie ND, Michiels JF, Wagner N.

Nat Commun. 2014 Dec 16;5:5852. doi: 10.1038/ncomms6852.


The basic N-terminal domain of TRF2 limits recombination endonuclease action at human telomeres.

Saint-Léger A, Koelblen M, Civitelli L, Bah A, Djerbi N, Giraud-Panis MJ, Londoño-Vallejo A, Ascenzioni F, Gilson E.

Cell Cycle. 2014;13(15):2469-74. doi: 10.4161/cc.29422.


The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter.

El Maï M, Wagner KD, Michiels JF, Ambrosetti D, Borderie A, Destree S, Renault V, Djerbi N, Giraud-Panis MJ, Gilson E, Wagner N.

Cell Rep. 2014 Nov 6;9(3):1047-60. doi: 10.1016/j.celrep.2014.09.038. Epub 2014 Oct 23.


Shading the TRF2 recruiting function: a new horizon in drug development.

Di Maro S, Zizza P, Salvati E, De Luca V, Capasso C, Fotticchia I, Pagano B, Marinelli L, Gilson E, Novellino E, Cosconati S, Biroccio A.

J Am Chem Soc. 2014 Dec 3;136(48):16708-11. doi: 10.1021/ja5080773. Epub 2014 Nov 19.


Biology of cancer and aging: a complex association with cellular senescence.

Falandry C, Bonnefoy M, Freyer G, Gilson E.

J Clin Oncol. 2014 Aug 20;32(24):2604-10. Review.


Trends and factors associated with self-reported receipt of preconception care: PRAMS, 2004-2010.

Oza-Frank R, Gilson E, Keim SA, Lynch CD, Klebanoff MA.

Birth. 2014 Dec;41(4):367-73. doi: 10.1111/birt.12122. Epub 2014 Jul 4.


The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.

Marçais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, Rabilloud J, Mayol K, Tavares A, Bienvenu J, Gangloff YG, Gilson E, Vivier E, Walzer T.

Nat Immunol. 2014 Aug;15(8):749-757. doi: 10.1038/ni.2936. Epub 2014 Jun 29.


Transcriptional outcome of telomere signalling.

Ye J, Renault VM, Jamet K, Gilson E.

Nat Rev Genet. 2014 Jul;15(7):491-503. doi: 10.1038/nrg3743. Epub 2014 Jun 10. Review.


A novel pathway links telomeres to NK-cell activity: Implications for immunotherapy.

Cherfils-Vicini J, Zizza P, Gilson E, Biroccio A.

Oncoimmunology. 2014 Jan 1;3(1):e27358.


Length-dependent processing of telomeres in the absence of telomerase.

Fallet E, Jolivet P, Soudet J, Lisby M, Gilson E, Teixeira MT.

Nucleic Acids Res. 2014 Apr;42(6):3648-65. doi: 10.1093/nar/gkt1328. Epub 2014 Jan 6.


Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis.

Salvati E, Zizza P, Rizzo A, Iachettini S, Cingolani C, D'Angelo C, Porru M, Randazzo A, Pagano B, Novellino E, Pisanu ME, Stoppacciaro A, Spinella F, Bagnato A, Gilson E, Leonetti C, Biroccio A.

Nucleic Acids Res. 2014 Mar;42(5):2945-57. doi: 10.1093/nar/gkt1289. Epub 2013 Dec 11. Erratum in: Nucleic Acids Res. 2014 Dec 16;42(22):14083.


Telomeric impact of conventional chemotherapy.

Lu Y, Leong W, Guérin O, Gilson E, Ye J.

Front Med. 2013 Dec;7(4):411-7. doi: 10.1007/s11684-013-0293-z. Epub 2013 Oct 23. Review.


Acacetin and chrysin, two polyphenolic compounds, alleviate telomeric position effect in human cells.

Boussouar A, Barette C, Nadon R, Saint-Léger A, Broucqsault N, Ottaviani A, Firozhoussen A, Lu Y, Lafanechère L, Gilson E, Magdinier F, Ye J.

Mol Ther Nucleic Acids. 2013 Aug 20;2:e116. doi: 10.1038/mtna.2013.42.


TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.

Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J, Simonet T, Horard B, Jamet K, Cervera L, Mendez-Bermudez A, Poncet D, Grataroli R, de Rodenbeeke CT, Salvati E, Rizzo A, Zizza P, Ricoul M, Cognet C, Kuilman T, Duret H, Lépinasse F, Marvel J, Verhoeyen E, Cosset FL, Peeper D, Smyth MJ, Londoño-Vallejo A, Sabatier L, Picco V, Pages G, Scoazec JY, Stoppacciaro A, Leonetti C, Vivier E, Gilson E.

Nat Cell Biol. 2013 Jul;15(7):818-28. doi: 10.1038/ncb2774. Epub 2013 Jun 23.


Supplemental Content

Loading ...
Support Center